In our continued examination of drug safety warnings, researchers with UBC's Therapeutics Initiative, and others found that warnings about heart risks associated with the antihistamine drug hydroxyzine led to reduced prescribing in the UK but...
In July 2021 we published a Therapeutics Letter on tramadol and advised our readers that "Health Canada has announced that it will add tramadol to Schedule I of the Controlled Drugs and Substances Act and...
[caption id="attachment_8212" align="alignright" width="300"] Dr. Anshula Ambasta, MD, MPH, FRCPC Assistant Professor, Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia[/caption] The Therapeutics Initiative is excited to extend a warm welcome to...
A new University of British Columbia study published in the journal Clinical Therapeutics has found that drug companies who sponsor clinical trials in Canada exert influence in some cases over whether the results of clinical...